恒顺醋业（600305）：25Q2盈利延续改善，关注后期经营变化

Investment Rating - The investment rating for the company is maintained at "Outperform" [2] Core Views - The company reported a 12.0% year-on-year increase in revenue for the first half of 2025, reaching 1.125 billion yuan, and a net profit of 111 million yuan, up 18.1% year-on-year. The second quarter saw a revenue of 499 million yuan, a decrease of 8.2% year-on-year, but a net profit increase of 40.61% year-on-year to 54 million yuan, aligning with market expectations [7][6] - The company is undergoing transformation and investment, with a projected net profit of 165 million, 207 million, and 241 million yuan for 2025 to 2027, reflecting year-on-year growth rates of 30%, 25%, and 16.5% respectively. The current market valuation corresponds to P/E ratios of 55x, 44x, and 38x for the respective years [7][6] - The company has outlined four strategic focuses: high-end positioning, national expansion, health empowerment, and youth engagement, which are expected to enhance operational performance and profitability [7] Financial Data and Profit Forecast - Total revenue projections for 2025 are set at 2.309 billion yuan, with a year-on-year growth rate of 5.2%. The gross profit margin is expected to be 36.6% [6][9] - The company’s gross margin for the first half of 2025 was 38.41%, an increase of 1.86 percentage points year-on-year, attributed to product mix optimization and cost reductions [7] - The company’s cash flow from sales in the first half of 2025 was 1.102 billion yuan, a 3.7% increase year-on-year [7]